Transcription factors (TFs) and microRNAs (miRNAs) regulate gene expression: TFs by influencing messenger RNA (mRNA) transcription and miRNAs by influencing mRNA translation and transcript degradation. Additionally, miRNAs and TFs alter each other's expression, making it difficult to ascertain the effect either one has on target gene (TG) expression. In this investigation, we use a two-way interaction model with the TF and miRNA as independent variables to investigate whether miRNAs and TFs work together to influence TG expression levels in colon cancer subjects. We used known TF binding sites and validated miRNA targets to determine potential miRNA-TF-TG interactions, restricting interactions to those with a TF previously associated with altered risk of colorectal cancer death. We analyzed interactions using normal colonic mucosa expression as well as differential expression, which is measured as colonic carcinoma expression minus normal colonic mucosa expression. We analyzed 3518 miRNA-TF-TG triplets using normal mucosa expression and 617 triplets using differential expression. Normal colonic RNA-Seq data were available for 168 individuals; of these, 159 also had carcinoma RNA-Seq data. Thirteen unique miRNA-TF-TG interactions, comprising six miRNAs, four TFs, and 11 TGs, were statistically significant after adjustment for multiple comparisons in normal colonic mucosa, and 14 unique miRNA-TF-TG interactions, comprising two miRNAs, two TFs, and 13 TGs, were found for carcinoma-normal differential expression. Our results show that TG expression is influenced by both miRNAs as well as TFs, and the influence of one regulator impacts the effect of the other on the shared TG expression.
enhancing its transcription, as well as indirectly through another regulator, such as a miRNA that also regulates that TG. 9 FFLs and FBLs are typically described as either "coherent" or "incoherent." FBLs are considered coherent when the TF and miRNA have the same effect (repression) on one another, and incoherent when the TF increases miRNA transcription, and the miRNA in turn represses the TF. 4 FFLs are considered coherent when the TF and indirect effector (in this instance a miRNA) have the same effect on the TG; when the TF and miRNA have opposing effects on the TG, this relationship is classified as an incoherent FFL. 9 FFLs illustrate the complexity of networks contributing to mRNA expression levels. Even in FBLs, miRNAs and TFs are highly connected, as the direct regulation of the TF by the miRNA has an indirect effect on all of the TGs regulated by the TF. 1, 8 The likelihood that observed levels of mRNA expression are the result of a combination of regulatory effects 7 makes only identifying specific miRNA-TG or TF-TG interactions difficult, and possibly unwarranted.
It is probable that biological interactions between miRNAs, TFs, and TGs as they occur in vivo may be better modeled when considering these molecules' activity concurrently rather than identifying simple interactions between specific TFs and TGs, or miRNAs and TGs. Additionally, little is known about the range of action the majority of miRNAs have. To expand the existing information on miRNA involvement in the carcinogenic process, a large-scale, discovery approach is needed to investigate jointly the global miRNA and mRNA activity. In this study, we use a two-way interaction model with the TF and miRNA as independent variables to investigate whether miRNAs and TFs work together in a FFL fashion to influence TG expression levels in colon cancer subjects. We hypothesize that TG expression is the product of combined TF and miRNA influences.
| M A TE RI A L S A ND M E TH ODS

| Study participants
Study participants were recruited as part of two population-based case-control studies that included all incident colon and rectal cancer between 30 and 79 years of age who resided in Utah or were of the Kaiser Permanente Medical Care Program (KPMCP) in Northern California (Table 1) . Participants were non-Hispanic white (NHW), Hispanic, or African American for the colon cancer study and also included participants of Asian race for the rectal portion of the study. 10, 11 Case diagnosis was verified by tumor registry data as a first primary adenocarcinoma of the colon and were diagnosed between October 1991
and September 1994 and for rectal were diagnosed between May 1997 and May 2001. Detailed study methods have been described. 12 All participants signed an informed consent. The Institutional Review
Boards at the University of Utah and at KPMCP approved the study.
| RNA processing
Formalin-fixed paraffin embedded (FFPE) tissue from the initial biopsy or surgery was used to extract RNA. Carcinoma tissue and adjacent normal mucosa were used to make RNA. Cells were dissected from 1 to 4 sequential sections on aniline blue stained slides using an H&E slide for reference. Total RNA was extracted, isolated, and purified using the RecoverAll Total Nucleic Acid isolation kit (Ambion); RNA yields were determined using a NanoDrop spectrophotometer. RNA was subsequently used for both miRNA and mRNA analyses.
| miRNA: Microarray analysis
The Agilent Human miRNA Microarray V19.0 was used. The microarray contains probes for 2006 unique human miRNAs as described previously. Data were required to pass stringent QC parameters established by Agilent that included tests for excessive background fluorescence, excessive variation among probe sequence replicates on the array, and measures of the total gene signal on the array to assess low signal. If samples failed to meet quality standards for any of these parameters, the sample was relabeled, hybridized to arrays, and re-scanned. If a sample failed QC assessment a second time, the sample was deemed to be of poor quality and the sample was excluded from analysis. Our previous analysis has shown that the repeatability associated with this microarray was extremely high (r 5 0.98), 12 and that comparison of miRNA expression levels obtained from the Agilent microarray to those obtained from qPCR had an agreement of 100% in terms of directionality of findings and that the fold change calculated for the miRNA expression difference between carcinoma and normal colonic mucosa was almost identical. 13 To normalize differences in miRNA expression that could be attributed to the array, amount of RNA, location on array, or factors that could erroneously influence miRNA expression levels, total gene signal was normalized by multiplying each sample by a scaling factors, which was the median of the 75th percentiles of all the samples divided by the individual 75th percentile of each sample. 14 
| mRNA: RNA-Seq library construction and processing
One hundred and eighty-seven samples were originally successfully run for normal colonic mucosa and 169 were run for colonic carcinoma tissue; in total 209 subjects had RNA-Seq successfully performed for either colonic carcinoma or normal colonic mucosa. These samples were taken from the study subjects used for miRNA analysis and were extracted, isolated, and purified as previously described. 15 RNA library construction was done with the Illumina TruSeq Stranded Total RNA Sample Preparation Kit with Ribo-Zero. The samples were then fragmented and primed for cDNA synthesis, adapters were then ligated onto the cDNA, and the resulting samples were then amplified using PCR; the amplified library was then purified using Agencount AMPure XP beads. A more detailed description of the methods can be found in our previous work. 16 Illumina TruSeq v3 single read flow cell and a 50 cycle single-read sequence run was performed on an Illumina HiSeq instrument. Reads were aligned to a sequence database containing the human genome (build GRCh37/ hg19, February 2009 from genome.ucsc.edu) and alignment was performed using novoalign v2.08.01. Counts were calculated for each exon and UTR of the genes using a list of gene coordinates obtained from http://genome.ucsc.edu. Total gene counts were determined. We dropped genes that were not expressed in our data or had limited expression for the majority of samples. 16 
| Statistical analysis
Our statistical analysis builds on our previous analysis of TF and miRNA pairs and survival in 168 colon cancer subjects. 17 In that analysis, we assessed 154 TFs with survival and identified 30 TFs with significant associations. 17 In this study, as a means of focusing our investigation on interactions that involve biologically important TFs, we restrict the analysis to miRNA-TF-TG triplets that include only these 30 TFs. Of the 30 TFs, 27
were associated with expression of 65 miRNAs in normal colonic mucosa, resulting in 719 TF-miRNA pairs. In this analysis, we further explored these TFs and miRNAs interactions in both normal colonic mucosa expression and carcinoma expression minus normal mucosa expression, which is hereafter referred to as differential expression, to test our hypothesis that TF and miRNAs work together to alter TG expression. One hundred and sixty-eight subjects had normal colonic RNA-Seq data and miRNA data available that passed quality control. Of these, 159 subjects also had paired colonic carcinoma RNA-Seq and miRNA data.
| miRNA-TF-TG triplet identification
The gene assembly used was GRCh37/hg19 for all coordinates. The UCSC as the interval 1/-300 bps straddling the TSS for a given gene. 20 Additionally, enhancers, including TFBSs, are known to occur downstream of and within the gene itself 21, 22 and this prompted us to apply the same 1/-300 bps to the end of the pri-miRNA transcript as well. PrimiRNAs were then matched to mature miRNAs, using the same coordinate file from miRBase. Using miRTarBase v6, 23 we identified TGs for the mature miRNAs whose corresponding pri-miRNA fell within a TFBS. These genes have been validated as targets for these miRNAs through different laboratory methods; all experimentally validated targets, identified by any experimental method, were used. Finally, TFBSs were downloaded from UCSC using the same table as the first step, however it was intersected with "Genes and Gene Predictions" group "knownGenes" table to get gene names for corresponding transcript
IDs. As these results are in the ensembl ID format, a second table,
"ensembleToGeneName" was used to find the gene names for these genes. The TGs were then paired up to TFs if a TFBS occurred 1/-300 bps from a TG start or end. Triplets were defined where a given TFBS overlapped with a pri-miRNA start site, whose mature miRNA end product has as a validated target a mRNA, whose transcription start or end also overlapped with the same TF. This was meant to represent TF regulation of the miRNA and TG, and miRNA regulation of the TG. In total, we identified 10,170 potential miRNA-TF-TG triplets meeting these criteria. These triplets model FFLs, in that they include a TF that binds near a TG as well as a miRNA, and a miRNA that has been shown to target the same TG. All coordinate matching was done using R scripting, and triplet determination was done using SQL commands.
| Dataset determination
We used identified miRNA-TF-TG triplets, and we restricted the TGs to those with a minimum fold change in expression between carcinoma and normal mucosa of 50% as had been done previously to the TFs and miRNAs. Using this list of triplets, we restricted the analysis to those 30 TFs and 65 miRNAs previously identified with survival. This resulted in 5707 triplets (i.e., miRNA-TF-TG) that included 11TFs, 17 miRNAs, 2901 TGs in normal mucosa expression, and 1267 triplets that included 8 TFs, 11 miRNAs, and 955 TGs for differential expression.
| TF-TG linear regression analysis
We fit least squares linear regression model between TF-TG using the reads per kilobase per million (RPKMs) expression levels. This provided a main-effect reference association for TGs, and served to limit the associations analyzed in the interaction analysis. P-values were generated using the bootstrap method to generate a distribution of 10,000 F statistics derived by resampling the residuals with replacement from the null hypothesis of no association between TF and TG expression using the "boot" package in R. 24 The linear models were adjusted for age, center, and sex. Multiple testing corrections were made using an false discovery rate of 0.05 or less. 25 This analysis determined 11 TFs and 1983 TGs in normal mucosa expression, and 7 TFs and 483 TGs in differential expression, were significantly associated.
| Interaction analysis
Finally, we examined the impact of interaction between the TF and miRNA upon the TG from the triplets that remain significant to this point (3518 triplets in normal mucosa expression, 617 triplets in differential expression). We used the bootstrap method to evaluate the statistical impact of the interaction term in the linear model also containing the TF and miRNA main effects. Thirteen triplets (6 miRNAs, 4 TFs, 11 TGs) in normal mucosa expression and 14 triplets (2 miRNAs, 2 TFs, 13 TGs) in differential expression had significant interactions between the TF and miRNA. We transformed the miRNA, TF, and TG to standard normal to calculated standardized beta coefficients to compare results across triplets after FDR correction.
| miRNA-TF linear regression
Previously, we performed a linear regression between TFs and miRNAs in normal colonic mucosa. In this analysis, we include the relevant results for normal colonic expression from our previous study, and we performed linear regressions between the same TFs and miRNAs, using the method described above, for differential expression. The beta coefficients derived from these analyses are labeled as "miRNA-TF Beta
Co." in Tables 2 and 3 . This was done to determine the effect of one regulator upon the other, as these associations are not detected in the interaction analysis.
| Bioinformatics analysis: Seed pairing and functional analysis
To assist in determining directionality of interactions, we analyzed the 3 0 UTRs of mRNAs for all TGs as well as TFs with negative miRNA-TFbeta coefficients with 5 0 miRNA seed sequences for matches. While our RNA-Seq data is aligned to the hg19 (GRCh37), as we used miRTarBase to identify validated miRNA-TG interactions, and this repository includes various experiments spanning years, we evaluated mRNA FASTA sequences for both the GRCh38 and GRCh37 alignments. A more detailed description of this process can be found in our previous work. 26 Ensembl was used to identify biological processes identified by the Gene Ontology (GO). Cytoscape was used to visualize miRNA-TF-TG interactions in normal colonic mucosa and differential expression (Figures 1 and 2) . We used the miRNA-TF-beta coefficient to describe the relationship between miRNAs and TFs, the TF-beta coefficient to describe the relationship between TFs and TGs, and the miRNA-beta coefficient to describe the relationship between miRNAs and TGs.
MiRNAs are shown as gray squares, TFs are shown as dark blue circles, and TGs are shown as light blue triangles. Positive beta coefficients are denoted with green arrows (!), while negative beta coefficients are denoted with red stops (-|). In such circumstances where a positive miRNA-beta coefficient as well as a seed match was identified between a miRNA and TG, we have shown this interaction with a red stop.
These instances are clearly noted in Tables 2 and 3 with footnotes. GO biological processes terms were identified using Ensembl's BioMart, with the GRCh37 assembly. To identify pathways that might be more meaningful to this set of genes, only pathways that were mapped to more than one gene were included.
| RE S U L TS
The study population is described in Thirteen unique miRNA-TF-TG interactions were statistically significant after adjustment for multiple comparisons in normal colonic mucosa; these interactions comprised six miRNAs, four TFs, and 11
TGs (Table 2, Figure 1 ). Three of these interactions, which included miRNAs hsa-miR-1258 and 145-5p, had positive interaction-betas, indicating that as TF expression increased, the relationship between the miRNA and TG became more positive, meaning that changes in expression were in the same direction. The remaining eight interactions, comprising miRNAs hsa-miR-150-5p, 193b-5p, 330-3p, 4469, had negative interaction-beta coefficients, indicating that as TF expression increased, the relationship between the miRNA and TG became more negative. These four miRNAs also had negative beta coefficients between TGs and miRNAs, reflecting an inverse relationship between the miRNA and TG. All of the interactions had positive TF-beta coefficients, reflecting a potential transcription activation of the TG by the TF. Eight of the 11 miRNA-TF/TG interactions with negative beta coefficients in normal colonic mucosa that were tested for seed matches had a confirmed match (Table 2 ).
There were 14 unique miRNA-TF-TG interactions found for differential expression, comprising two miRNAs, two TFs, and 13 TGs (Table   3 , Figure 2 ). Thirteen of these interactions, including miRNAs 23a-3p
and 4469, had negative interaction-beta coefficients, and one, between hsa-miR-23a-3p, ELF1 (TF), and ADAM28 (TG) had a positive interaction-beta coefficient. A negative miRNA-beta coefficient was found between hsa-miR-23a-3p and ADAM28, CCT5, GMPS, NACC1, and SSRP1; all other interactions had positive miRNA-beta coefficients.
A negative miRNA-TF-beta coefficient also was seen between hsamiR-4469 and ELF1 (TF). All five of the miRNA-TF and miRNA-TG pairs tested for seed matches had a confirmed match using both alignments (Table 3 ).
| D I SCUSSION
Thirteen unique miRNA-TF-TG interactions were significantly associ- had a TFBS within 1/-300 bps of these miRNAs' primary sequences, it is also possible that the TF represses the miRNA in turn, as is the case in some coherent FFLs. 4 Seed matches were also identified between hsamiR-330-3p and PTPLAD1 as well as between hsa-miR-4469 and MRPS27, supporting the negative miRNA-beta coefficients for these interactions and indicating these miRNAs repress these TGs. 
GMPS, IMPDH2
Purine nucleobase metabolic process
Purine nucleotide biosynthetic process
Purine ribonucleoside monophosphate biosynthetic process
CNOT6, MYC, SSRP1
Regulation of transcription, DNA-dependent RRM2 GMPS, GNB2, IMPDH2, LDHA Small molecule metabolic process
Viral process a Pathways that were regulated by more than one TG were included in the table. Lines shaded in gray contain pathways that were identified for more than one TG in both normal and differential colonic mucosa.
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The other eight interactions that involved negative interactionbeta coefficients, displayed positive miRNA-TF-beta coefficients, most likely indicating miRNA transcription enhancement by the TF, or indirect effects on the miRNA expression. All 10 interactions with negative interaction-beta coefficients also displayed negative miRNA-beta coefficients, indicating TG repression by miRNAs. Seed pairing was identified in six of these interactions, between MAPK1IP1L and hsa-miR193b-3p, MRPS27 and hsa-miR-4469, PTPLAD1 and hsa-miR-330-3p, RAD51 and hsa-miR-193b-3p, RRM2 and hsa-miR-193b-3p, and VEGFA and hsa-miR-150-5p, supporting the theory that these interactions involve miRNA repression of the TG.
The three miRNA-TF-TG interactions identified in normal colonic mucosa that displayed positive interaction-beta coefficients involved miRNAs hsa-miR-1258 and 145-5p and TFs ZNF263, CTCF, and ELF1.
A negative miRNA-TF-beta coefficient was identified between hsamiR-1258 and ZNF263, and a seed match was identified between hsamiR-1258 and the 3 0 UTR of ZNF263, suggesting that hsa-miR-1258
represses ZNF263. This study was performed using FFPE tissue. While it is true that these samples have a greater risk of being fragmented, our paired data allows us to control for expression changes that may be due to differences in collection and storage across samples and we have achieved a high level of replication for the microarray platform with our FFPE data. 32 Additionally, obtaining RNA from FFPE is the only way that large studies such as this can be done to obtain RNA for both miRNA and mRNA. We were only able to look at mRNA gene expression, and as such we are only able to detect evidence of mRNA degradation and not necessarily partial miRNA binding, which results in translation inhibition without degradation of the transcript. As such, we have potentially missed important interactions resulting in decreased protein production. We encourage others to validate these findings. Negative beta coefficients may reflect repression of either molecule on the other and as such these findings should be replicated in laboratory experiments to verify directionality and whether the findings represent direct or indirect effects. In interactions involving a miRNA, we were able to look for seed pairings, which, when present, support the theory that it is the miRNA that is degrading the gene (be it a TF or TG), however it is possible that other influencing factors have not been identified. It is also possible that other definitions of seeds would have resulted in seed matches; however, as many of our tested pairs did have an identified match, we do not believe this significantly limited our investigation.
Additionally, mRNA degradation typically results from longer, continuous seed pairing, 2 which is what we search for, and this is appropriate for our mRNA dataset. We chose to look only at miRNA-TF-TG triplets (FFLs) rather than interactions in which the miRNA and TF do not share TGs (FBLs). These interactions may be less common than FBLs, and in this decision may have omitted important interactions from the analysis, however we do not feel that this detracts from our findings. Our objective in this study was to elucidate the intricate relationship between TFs and miRNAs, and how they influence each other's effect on TG expression. This approach can be applied to different scenarios and other data types to elucidate other important biological interactions. We did not take consider intronic miRNAs, which may have altered where we looked for TFBS overlap. As we performed miRNA-TF linear regressions that confirm significant associations in expression between miRNAs and TFs identified by coordinate overlap we do not believe that our criteria have misidentified miRNA-TF associations, however it is possible that we excluded meaningful interactions. Additionally, while we chose our TFBS overlap with miRNA and TG transcripts deliberately and with evidentiary support, the number of bps is somewhat arbitrary and different overlap criteria may yield different results. Our dataset, while relatively small (N 5 168), is still larger than most studies containing miRNA and mRNA data. We consider our dataset to be an asset to this investigation, as we were able to investigate paired miRNA and mRNA data with expression from both tumor and paired normal samples for a large number of individuals; however, it is possible that, given the study size and the adjustment for multiple comparisons, we may have missed detecting relevant associations. Furthermore, many exogenous and endogenous factors that we did not take in to consideration in this investigation are able to influence both miRNA and mRNA expression. 
